If you have any questions for next week's webinar guest speakers (Pyx Resources, Helix Exploration, Fulcrum Metals and Metals One), please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 252.60
Bid: 251.60
Ask: 252.00
Change: -0.80 (-0.32%)
Spread: 0.40 (0.159%)
Open: 254.00
High: 254.00
Low: 250.80
Prev. Close: 253.40
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Man Group PLC : Form 8.3 - International Paper Company

23 Apr 2024 12:16

Man Group PLC : Form 8.3 - International Paper Company

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Man Group PLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeInternational Paper Company
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure22/04/2024
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES / NO / N/AOfferee – Smith (DS) plc

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:common stock
 InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:   105,8220.03
(2) Cash-settled derivatives:   1,030,6920.30
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:   1,136,5140.33

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
common stockSale4,40034.760 USD
common stockSale1,50034.760 USD
common stockSale40034.760 USD
common stockSale60034.760 USD
common stockSale40034.760 USD

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
common stockEquity SwapIncreasing a short position8,63634.774 USD
common stockEquity SwapIncreasing a short position12,29934.774 USD
common stockEquity SwapIncreasing a short position2,55834.774 USD
common stockEquity SwapIncreasing a short position200,38834.774 USD
common stockEquity SwapIncreasing a short position8,72334.774 USD
common stockEquity SwapIncreasing a short position2,20434.774 USD
common stockEquity SwapIncreasing a short position1,24634.774 USD
common stockEquity SwapIncreasing a short position50,68634.774 USD

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:23/04/2024
Contact name:Mackenzie Terry
Telephone number:+442071441555

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
20th Mar 20245:50 pmRNSTransaction in Own Shares
19th Mar 20245:40 pmRNSTransaction in Own Shares
19th Mar 20243:00 pmRNSTreasury Share Cancellation & Total Voting Rights
18th Mar 20245:45 pmRNSTransaction in Own Shares
15th Mar 20246:01 pmRNSTransaction in Own Shares
14th Mar 20245:52 pmRNSTransaction in Own Shares
14th Mar 202410:15 amRNSESEF Annual Report 2023
13th Mar 20245:37 pmRNSTransaction in Own Shares
12th Mar 20246:00 pmRNSTransaction in Own Shares
11th Mar 20246:25 pmRNSTransaction in Own Shares
11th Mar 20245:10 pmRNSDirector/PDMR Shareholding
11th Mar 20245:06 pmRNSDirector/PDMR Shareholding
11th Mar 20245:03 pmRNSDirector/PDMR Shareholding
8th Mar 20245:37 pmRNSTransaction in Own Shares
8th Mar 20243:45 pmRNSAnnual Financial Report
7th Mar 20245:45 pmRNSTransaction in Own Shares
6th Mar 20246:17 pmRNSTransaction in Own Shares
5th Mar 20246:00 pmRNSTransaction in Own Shares
5th Mar 20247:00 amRNSShare buyback programme of up to $50million
1st Mar 20247:00 amRNSTotal Voting Rights
29th Feb 20241:17 pmGNWMan Group PLC : Form 8.3 - Ageas SA/NV
29th Feb 20247:00 amRNSFinancial Results For The Year Ended 31 Dec 2023
1st Feb 20247:00 amRNSTotal Voting Rights
5th Jan 20247:00 amRNSDirectorate Change
2nd Jan 20247:00 amRNSTotal Voting Rights
12th Dec 20235:06 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTotal Voting Rights
19th Oct 20237:00 amRNSTrading Statement Q3 2023
2nd Oct 20237:00 amRNSTotal Voting Rights
13th Sep 202312:00 pmRNSDirectorate Change
7th Sep 20237:00 amRNSCompletion of Varagon Capital Partners acquisition
5th Sep 202312:45 pmRNSDirector/PDMR Shareholding
1st Sep 20239:30 amRNSInterim Dividend - Sterling Conversion Rate
1st Sep 20237:00 amRNSTotal Voting Rights
25th Aug 202311:15 amRNSDirectorate Change
21st Aug 20234:00 pmRNSDirector/PDMR Shareholding
1st Aug 20239:30 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSHalf year results for the period ended 30 June 23
6th Jul 20237:00 amRNSMan Group to acquire Varagon Capital Partners
3rd Jul 20237:00 amRNSTotal Voting Rights
14th Jun 20233:15 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSTotal Voting Rights
24th May 20233:50 pmRNSDirector/PDMR Shareholding
15th May 20235:40 pmRNSTransaction in Own Shares
12th May 20235:30 pmRNSTransaction in Own Shares
11th May 20236:02 pmRNSTransaction in Own Shares
11th May 20237:00 amRNSMan Group appoints next CEO
10th May 20235:41 pmRNSTransaction in Own Shares
9th May 20235:55 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.